CALGARY, AB / ACCESSWIRE / FEBRUARY 27, 2019 / Asia Cannabis Corp. ("ACC" or the "Company") (CSE:ASIA), announced today that it has granted an aggregate of 550,000 stock options (each, an "Option") to a director of the Company in accordance with the Company's stock option plan. Each Option is exercisable into one common share in the capital of the Company (each, a "Share") at a price of $0.25 per Share for a period of five years from the date of grant. Including this grant of Options, the Company has granted less than 100% of the Options available for grant under its stock option plan.
ACC is an early stage international agri-technology company which has begun the process of creating a business focused on the development, evaluation, testing, application and, ultimately, supply to the market of proprietary organic hybridization technology and certain products derived from that technology. The core approach of the business will be centred on the planting, growth and harvesting of new and valuable strains of hemp and related crops in commercial quantities under the terms of the InPlanta License Agreement.
In conjunction with InPlanta, the Corporation plans to develop varieties of hemp with superior growth and production characteristics in the various environments found in the licensed territories With the data and associated knowledge gained from these activities, the Corporation intends to leverage the technology to develop a portfolio of strategic hemp investments to take advantage of both the changing social climate relative to hemp use and the historic acceptance of the use of these products and their derivatives in certain of the jurisdictions granted under the License Agreement.
For further information, contact:
Chief Executive Officer
Neither the CSE nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.
SOURCE: Asia Cannabis Corp.
View source version on accesswire.com: